emanuel program1  

Cras ultricies mi eu turpis hendrerit fringilla. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; In ac dui quis mi consectetuer lacinia.

Test program add @123234  

No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track

This study aims to assess the no-reflow in patients with STEMI after intracoronary glycoprotein IIb/IIIa inhibitors after opening of track in thrombus.

Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis

Myocardial necrosis is examined and quantified by cardiac MR. Healthy volunteers, chest pain patients who will receive CAG or CTA examination, and patients with acute myocardial infarction will be enrolled in this study.

virtualtesting  

Text in a pre element is displayed in a fixed-width font, and it preserves both spaces and line breaks.(*) Coronary heart disease (CHD), cerebrovascular manifestation, peripheral arterial occlusive disease (PAOD) (**) For cardiovascular events (e.g. diabetes mellitus, renal function glomerular filtration rate (GFR) < 60 ml/min) Exclusion Criteria: - Planned …

None

None

None

None

None